New Jersey's Johnson & Johnson grew from one ambitious pharmacist to a $94 billion pharmaceutical and medical device giant.
New research from researchers at the University of Florida, University of Maryland and Yale School of Public Health has found that if measles, mumps and rubella (MMR) immunization rates continue to ...
Biogen could see lower royalties for Ocrevus after its patent expires , but it has developed other medicines that will ...
Telix Pharmaceuticals Ltd (ASX:TLX) has delivered a sharp reminder of how quickly sentiment can swing in biotech — with a ...
April 13 (Reuters) - Alamar Biosciences and Kailera Therapeutics kicked off roadshows for their U.S. initial public offerings ...
In this edition of the biotech bi-weekly, get the latest biotech industry updates, with special focus on the upcoming AACR ...
CHENGDU, China, April 14, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ('Kelun-Biotech' or the 'Company', 6990.HK) announced that results from both the ovarian cancer cohort ...
Sana and Mayo Clinic to collaborate across multiple areas with goal of accelerating development of and access to potentially curative therapies for patients with type 1 diabetes Initial efforts will ...
Initial data from first cohort in LA-PDAC show 66% (2/3) patients resected following VTP at lowest light dose with a consistent and well-tolerated safety profile - ...
Immutep shares rocket after a fresh FDA win The post Why this ASX biotech stock just rocketed 89% today appeared first on The ...
Starting up in a garage isn’t an option for life sciences companies that do things like analyze microbes and test saliva samples. They need laboratory space, which is in short supply in Minnesota.
CAR-T therapies are continuing to gain traction in autoimmune disease, with a notable new case. Also, the FDA has withdrawn ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results